Related Experiment Video
Updated: Jul 17, 2026
07:14
Ookluc: A Plasmodium berghei Line for Identifying Transmission-blocking Compounds
Published on: July 11, 2025
Artemisinin-class combination therapy for malaria-unresolved ethical and technical issues
1School of Public Health and Tropical Medicine, James Cook University, Townsville 4811, Australia.
Travel Medicine and Infectious Disease
|February 13, 2007
Summary
Artemisinin-class Combination Therapy (ACT) is effective for uncomplicated malaria. Improved pharmacovigilance and accessibility are crucial for global malaria control efforts.
Area of Science:
- Global Health
- Infectious Diseases
- Pharmacology
Background:
- Artemisinin-class Combination Therapy (ACT) is key to reducing malaria mortality.
- Existing evidence supports ACT efficacy for uncomplicated malaria.
- Methodological weaknesses in current safety studies necessitate enhanced pharmacovigilance.
Purpose of the Study:
- To highlight the critical role of ACT in malaria control.
- To emphasize the need for robust pharmacovigilance for ACT safety.
- To discuss the ethical considerations surrounding ACT adoption.
Main Methods:
- Review of existing evidence on ACT efficacy and safety.
- Analysis of pharmacovigilance requirements for antimalarial drugs.
- Ethical framework analysis related to public health interventions.
Main Results:
- ACT is a proven, effective treatment for uncomplicated malaria.
- Current ACT safety data is limited by methodological issues.
- Limited ACT availability has raised ethical concerns regarding access.
Conclusions:
- Ongoing, sensitive pharmacovigilance for ACT is urgently needed.
- Ensuring ACT availability is essential for public health.
- Ethical principles must guide the implementation of ACT as first-line malaria therapy.
Related Concept Videos
01:29Malaria
Malaria pathogenesis in humans reflects a delicate interplay between parasite biology and host response. Clinical illness reflects a host’s immune response to the parasite’s asexual replication cycle, which is often asymptomatic in individuals with partial immunity. From the parasite's perspective, transmission between mosquito and human with minimal host pathology is evolutionarily advantageous. Among the six Plasmodium species infecting humans, P. falciparum and P. vivax dominate in global...
01:15Anthelminthic Agents
Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...
01:21Antiprotozoal Agents
Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
01:27Combined Effects of Drugs: Synergism
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...